NASA Moon Probe Sheds Light on Space Radiation Risks

A NASA moon probe equippd with plastic that mimics living tissue is helping researchers learn how deep-space radiation may affect astronauts and electronics on future missions, researchers say.

These findings could lead to the development of leaner, more efficient spacecraft that are better at balancing radiation protection against weight, scientists added.

Potentially dangerous radiation pervades outer space, such as electrically charged particles from the sun and high-mass, high-energy cosmic rays known as HZE particles that emerge from deep space. Earth's atmosphere and magnetic field block about 99.9 percent of this radiation, protecting those of us on the planet's surface. [Stunning Photos of Solar Flares & Sun Storms]

"The atmosphere serves as just a big thick shield the weight exerted by the atmosphere is equivalent to a column of mercury about 30 inches (76 centimeters) high, so you can think of the atmosphere as a huge slab of dense metal a yard thick,"study lead author Mark Looper, a space radiation physicist at The Aerospace Corporation in El Segundo, Calif., told SPACE.com. "The magnetic field, in addition, shunts aside most of the radiation from Earth's surface."

To find out more about radiation hazards in space, Looper and his colleagues are relying on the Cosmic Ray Telescope for the Effects of Radiation instrument (CRaTER) aboard NASA's Lunar Reconnaissance Orbiter, which has been zipping around the moon at an altitude of about 30 miles (50 kilometers) since 2009.

CRaTER aims to measure not only radiation near the moon, but also the effects radiation has on sensitive materials such as human tissue or electronic parts that might absorb it behind shielding. The instrument uses sensors behind blocks of plastic designed to mimic the muscle tissue over a person's radiation-sensitive bone marrow.

"We've never had such tissue-equivalent plastics as part of a complex sensor in space before," Looper said.

The researchers found that although HZE particles only make up 1 percent or so of the radiation the telescope saw, "they made up close to half of the energy deposited by radiation," Looper said. "You get much more energy deposited by these heavies."

By looking with precision at the range of energies deposited by various sources of radiation, scientists can estimate the effects they might have. "It's like the difference between being hit with a bat or a bullet different kinds of radiation may deposit the same amount of energy, but they distribute it differently," Looper said.

Altogether, these findings could help researchers optimize just how much shielding spacecraft need without making them too heavy for missions.

See original here:

NASA Moon Probe Sheds Light on Space Radiation Risks

Space Station Lands in Houston in State-of-the-Art NASA Exhibit

NASA has a new "stage" to expose and educate the public about the work behind and on board the International Space Station.

More than a year in the making, NASA and Space Center Houston, the visitor center for the agency's Johnson Space Center in Texas, put the final touches on a new interactive exhibit and special effects live stage show that highlights how the orbiting outpost came to be, what life is like on board and how it is being used to conduct science.

The 3000-square-foot (280 square meters) display was inspired by NASA's traveling exhibit "Destination Station" (hosted currently at Atlanta's Fernbank Science Center until May 18). But instead of simply recreating the mobile exhibition, NASA's International Space Station Program worked with the external relations office at Johnson and Space Center Houston to enhance and expand the display into a brand-new experience for guests. [Building the International Space Station (Photos)]

"This [new] exhibition highlights, through the use of a live performance, static graphic elements, hardware, astronaut personal effects, video content and interactive software programs, the international partnership which assembled this orbiting laboratory, its human presence which works and lives on board, and the complex research and science that is taking place which benefits all humankind," NASA wrote about the exhibit.

Destination Station 2.0

Space Center Houston began building the exhibit about a year ago by reconfiguring the International Space Station or rather a large detailed model of the orbiting complex.

Suspended from the ceiling, the scale model was updated to reflect the final assembly of the space station, including removing a once-docked replica of the now-retired space shuttle. The model was then re-hung in front of a mural of the Earth, placing it into the context of the new display.

Underneath the not-so-miniature station is a new mockup of a Mission Control console. Nearby, one of the canisters used to transport the orbiting laboratory's power-providing solar arrays is also on display with a sample strip of the cells used to generate electricity for the station.

The Mission Control monitors display the "Space Station Live!" website, which provides access to live data from the real space station as received through the real Mission Control, located nearby at the Johnson Space Center. Not only can visitors use the replica console to learn what the astronauts and cosmonauts on board the station are doing in space in real time, but they can find when the orbiting complex can be seen flying over their homes.

Venturing further into the exhibit, guests can see a training mockup of the space station's multi-window Cupola, a full-size model of the outpost's robotic resident Robonaut 2, and look inside both a crew member's living quarters and the onboard waste containment system, or toilet.

See the original post:

Space Station Lands in Houston in State-of-the-Art NASA Exhibit

TSI Healthcare Selects Local Practice, Carolina Orthopaedic and Sports Medicine Center, as "Circle of Excellence Award …

CHAPEL HILL, N.C., April 16, 2013 /PRNewswire/ --TSI Healthcare, a national leader in the sales and support of customized healthcare information technology, celebrates Carolina Orthopaedic and Sports Medicine Center's selection as winners of the annual "Circle of Excellence Award" in the Practice Management System category. Established in 2009, the award recognizes practices that have positioned themselves as leaders in Healthcare IT and champions of improved patient care through the use of Electronic Health Records and Practice Management systems. The award focuses on key indicators that measure efficiency, regulatory compliance, and delivery of quality care through the use of technology.

Practice Manager Chad Ghorley from Carolina Orthopaedic and Sports Medicine Center of Gastonia, NC commented, "As physicians strive for better care, the use of technology is key. Health IT results in improved efficiency, increased revenues, while allowing us to focus on our patients. Partnering with a vendor that provides the necessary resources and customer service is equally as important. The "Circle of Excellence" award is an example of TSI Healthcare's dedication to our practice. It allows our group to benchmark our system use, encouraging staff to master basic functionality and try new features. Ultimately, using a top-notch Practice Management system helps us drive improved patient satisfaction through efficient business workflows."

TSI Healthcare's President and CEO, David Dickson Jr. adds, "Carolina Orthopaedic and Sports Medicine Center is a true leader in the healthcare community. In fact, our survey found key attributes that show exceptional commitment to improving the patient experience. Their team has worked diligently to attain maximum use of their systems and serve as an outstanding example for other practices. We are proud to work alongside groups like Carolina Orthopaedic and Sports Medicine Center, who are seeking to bring healthcare to the twenty-first century."

About Carolina Orthopaedic and Sports Medicine Center

Carolina Orthopaedic & Sports Medicine Center (COSMC) is proud of its long heritage of providing expert orthopaedic care in the Piedmont area, dating back to the original North Carolina Orthopaedic Hospital which was also located in Gastonia, NC. COSMC's team of highly-trained and talented orthopaedic surgeons, a physiatrist and physician assistants offers quality care and strives to provide exceptional customer service to the patients and family members whom they serve. For more information about COSMC, visit the practice website at http://www.carolinaorthopaedic.com.

About TSI Healthcare

TSI Healthcare, Inc. was founded in 1997 and empowers physicians to improve care, increase efficiency and maximize profitability through the successful implementation and utilization of the NextGen integrated EPM and EHR Systems. Each of TSI's solutions are customized, managed and designed to serve the unique needs of the client and the individual practice needs. TSI Healthcare's support and service teams include NextGen Certified Professionals, clinical experts, former practice administrators, and EHR and Practice Management Consultants. For more information, visit http://www.tsihealthcare.com or call 800-354-4205.

Contact: Christian Mibelli TSI Healthcare 800-354-4205 101 Europa Drive, Suite 200 Chapel Hill, NC 27517

See the original post:

TSI Healthcare Selects Local Practice, Carolina Orthopaedic and Sports Medicine Center, as "Circle of Excellence Award ...

Eight New Addiction Medicine Fellowship Programs Accredited

Eight new addiction medicine fellowship programs have been accredited by the American Board of Addiction Medicine (ABAM) Foundation, bringing the total number of programs to 18, Newswise reports.

Doctors who complete one of these fellowships are eligible to sit for the ABAM exam to become certified in addiction medicine. There are 47 addiction medicine fellowship slots available, although some slots are not yet funded, according to the article.

These new fellowships will help insure that trained addiction medicine physicians join other addiction professionals in the interdisciplinary care of patients with addictive disorders, said Jeffrey H. Samet, MD, MA, MPH, President of ABAM and the ABAM Foundation Board of Directors. This clinical training, coupled with passage of our rigorous examination, will help to provide evidence-based addiction treatment to those who need it.

The new fellowship programs are located at the Betty Ford Center/Eisenhower Medical Center, Rancho Mirage, California; Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Hartford Hospital, Hartford, Connecticut; St. Joseph Mercy Hospital Ann Arbor, Ypsilanti, Michigan; St. Pauls Hospital, Vancouver, British Columbia, Canada; St. Vincent Charity Medical Center, Cleveland, Ohio; Stanford Hospital and Clinics, Stanford, California; and Yale-New Haven Hospital, New Haven, Connecticut.

Our workforce projections suggest that, by 2020, we will need 50 addiction medicine fellowship training programs with 200 physician slots, said Richard Blondell, MD, Chair of the Foundations Training and Accreditation Committee. One of the main obstacles to establishing these programs is funding.

Demand for addiction treatment will expand as the Affordable Care Act adds millions of new patients to the system. Addiction medicine courses are rarely offered in medical school, the article notes.

Here is the original post:

Eight New Addiction Medicine Fellowship Programs Accredited

Popular Chinese medicine used for migraines could be FATAL, warn watchdogs

Zheng Tian Wan is unregulated but available in the UK Medicine contains herb known as Queen of Poisons Could be toxic for the heart and nervous system Experts urge anyone who has taken herb to visit GP

By Rachel Reilly

PUBLISHED: 11:40 EST, 17 April 2013 | UPDATED: 11:40 EST, 17 April 2013

The plant remedy contains aconite a herb once dubbed the 'Queen of Poisons'

A herbal medicine used by alternative practitioners to treat migraines could be fatal.

Zheng Tian Wan is unregulated but is available in the UK, and it has been linked to serious health complications and death, health authorities say.

The plant remedy contains aconite a herb once dubbed the Queen of Poisons by the ancient Greeks - and could be toxic for the heart and nervous system.

The ingredient is on a UK list of restricted herbal ingredients and the Medicines and Healthcare products Regulatory Agency (MHRA) have issued a statement warning against using the product.

The MHRA said the issue came to their attention after a herbal practitioner supplied a patient the unlicensed migraine pills, which have not been tested for safety and quality.

The agency said it has previously received three reports of suspected side effects to aconite.

The rest is here:

Popular Chinese medicine used for migraines could be FATAL, warn watchdogs

Two Science Translational Medicine Reports: DREAM and Sage Bionetworks Tap into the Wisdom of the Crowd to Fight the …

SEATTLE--(BUSINESS WIRE)--

Two new reports issuing in Science Translational Medicine (STM) today showcase the potential of teams of scientists working together to solve increasingly complex medical problems.

The results demonstrate that better predictors of breast cancer progression than those currently available can be rapidly evolved by running open Big Data Challenges such as The Sage Bionetworks/DREAM Breast Cancer Prognosis Challenge (BCC).

In breast cancer, a key undertaking is determining those patients whose disease is most likely to progress rapidly and therefore tailor the best course of treatment for them. Currently oncologists are using gene-expression based assays such as MammaPrint and Oncotype Dx, that are based on 10 year old science, and both do better with breast cancer risk prediction than models based only on clinical data.

Dr. Stephen Friend, the Founder of Sage Bionetworks and one of the organizers of the BCC reflects, Ten years ago, members of our research group used gene expression profiling to build one of the first breast cancer predictors. Mammaprint and Oncotype Dx were developed off of that but further improvement seems to have stalled. We wondered if running a Challenge like BCC would motivate lots of different groups to tackle this problem, some working collaboratively, and if that might be more fruitful than the current 'go it alone' single researcher approach.

To push the envelope on all the innovations that could be incorporated into the BCC, Sage partnered with the DREAM Project, a visionary distributed systems biology group that has run 24 successful open computational challenges over the last five years.

DREAMs founder and leader, Dr. Gustavo Stolovitzky saw the BCC as an opportunity to, refocus our efforts to create a collaborative research environment that fosters a complementary way of doing science, which accelerates the pace of discovery with the goal of contributing to a faster reduction of suffering due to disease. This seems to me like an ethical imperative.

The goal of the BCC was to build a computational model that accurately predicts breast cancer survival. To do this, participants of the Challenge used genomic and clinical information from 2000 women diagnosed with breast cancer (theMETABRIC data set). They accessed this data on Synapse, Sage Bionetworks open compute platform for data sharing and analysis: Google donated cloud-based standardized virtual machines that each participant used to train their models against the data. Individual participants and/or teams submitted their computational models to Synapse as open source code made viewable to all: their models were assessed against a hidden dataset and their scores were reported on a real-time leaderboard. The combination of immediate feedback and code-sharing allowed participants to improve their leaderboard ranking by adjusting their own models or by borrowing the code of others to forge new models.

Throughout the July-October 2012 model-training phase, a crowd of 350 players from 35 countries across the globe joined the Challenge and submitted a total of 1700 computational models for scoring. The winning model was determined by scoring the predictive accuracy of players models against a newly generated data set: for this, the Avon Foundation For Women funded the generation of gene expression and copy number data as well as collection of corresponding clinical information from 180 breast cancer patients. Finally, the BCC organizers recognized that the basic science community might be most energized to participate if the Challenge prize were not money but the invitation to publish an article about the winning model in a top tier journal. The editors of STM saw the unique opportunity to run their own experiment on how to structure the peer-review process for competition-based crowdsourcing studies such as the BCC. Todays issue of STM features not only the winners article (the BCC Challenge prize) and a report from the BCC organizers on the Challenges conception, execution and insights -- STM also chose to highlight the BCC with an Editorial Summary and an iconic cover of Rosie the Riveter, intended to symbolize the power of women and their data to transform health.

Quipped Challenge participant Richard Savage (MRC Fellow in Biostatistics at the University of Warwick) on the prospect of winning the opportunity to publish in STM, This is huge and a genuinely new way to do some great science. I really think the organizers are onto something with this.

Go here to see the original:

Two Science Translational Medicine Reports: DREAM and Sage Bionetworks Tap into the Wisdom of the Crowd to Fight the ...

Precision for Medicine, Inc. Appoints Former FDA Advisor Vicki Seyfert-Margolis as Chief of Science and Strategy

CHEVY CHASE, Md.--(BUSINESS WIRE)--

Precision for Medicine, Inc. (Precision) today announced that Vicki Seyfert-Margolis PhD has joined the company as Chief of Science and Strategy. Dr. Seyfert-Margolis joins Precision from the U.S. Food and Drug Administration (FDA) where she served as Senior Advisor, Regulatory Science and Innovation, reporting to the Commissioner. In that role, Dr. Seyfert-Margolis was responsible for spearheading the FDAs regulatory science and personalized medicine initiative, the agencys strategy for promoting innovative approaches in drug development, strategies for big data and scientific computing, as well as policies and guidance for companion diagnostics and co-development. Prior to the FDA, Dr. Seyfert-Margolis was Chief Science Officer at the Immune Tolerance Network, a global research initiative to discover biomarkers for autoimmune disorders.

We are proud to have Vicki join the Precision leadership team, said Mark P. Clein, President. She brings a rare combination of scientific credibility, industry expertise, and an intimate understanding of the factors that are driving modern regulatory decision-making, innovation, and policy. She will play a critical role in guiding our scientific strategy and providing insight and support for our clients.

Precision for Medicine shares my vision for the future of health care one where the patient is not just the end user, but the focal point of all aspects of drug, diagnostic, and device development, said Dr. Seyfert-Margolis. The patient becomes central throughout the product lifecycle. Real world information will be as important as sequencing in developing targeted medications and identifying the best treatment paradigms. I am excited to help build what is truly a next generation service company to support the innovators of tomorrows medical products.

About Precision for Medicine

Precision for Medicine is a specialized service company providing services and infrastructure to support life science companies as they develop new products in the age of precision medicine. Precision brings expertise, technology, and project execution to support innovative, patient centric solutions from discovery through commercialization. The company is headquartered in Chevy Chase, MD with offices in Gaithersburg, MD, Frederick, MD and Cambridge, MA. For more information about Precision, visitwww.precisionformedicine.com.

Read this article:

Precision for Medicine, Inc. Appoints Former FDA Advisor Vicki Seyfert-Margolis as Chief of Science and Strategy

Eight Addiction Medicine Fellowship Programs Accredited by ABAM Foundation

Newswise The American Board of Addiction Medicine (ABAM) Foundation today announced the accreditation of eight addiction medicine fellowship programs, bringing the total number of accredited programs to 18. Physicians who complete an ABAM Foundation fellowship are eligible to sit for the ABAM certification examination in order to become board certified in addiction medicine.

The fellowship programs, which are modeled on the Foundations national guidelines, Program Requirements for Graduate Medical Education in Addiction Medicine, are based at leading medical institutions across the U.S. and Canada. Accreditation of these new programs means that there are now 47 addiction medicine fellowship slots available, although some slots are not yet funded.

These new fellowships will help ensure that trained addiction medicine physicians join other addiction professionals in the interdisciplinary care of patients with addictive disorders, said Jeffrey H. Samet, MD, MA, MPH, President, ABAM and ABAM Foundation Board of Directors, and Professor of Medicine at Boston University School of Medicine. This clinical training coupled with passage of our rigorous examination will help to provide evidence-based addiction treatment to those who need it.

The new fellowship programs are located at the Betty Ford Center/Eisenhower Medical Center, Rancho Mirage, CA; Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Rushford, A Hartford HealthCare Partner, Middletown, CT; St. Joseph Mercy Hospital Ann Arbor, Ypsilanti, MI; St. Pauls Hospital, Vancouver, British Columbia, Canada; St. Vincent Charity Medical Center, Cleveland, OH; Stanford Hospital and Clinics, Stanford, CA; and Yale-New Haven Hospital, New Haven, CT (see end of release for more detail).

We greatly value medical education and this ABAM Foundation accreditation acknowledges this, said James W. Golden, MD, Program Director, Betty Ford Center Addiction Medicine Fellowship Program. We take this very seriously and are ready to step up to the plate to do the vital work necessary to educate physicians on the prevention and treatment of addictive disorders and medical and psychiatric complications of addiction. This accreditation is a validation that the Betty Ford Center has the expertise in both faculty and staff to accomplish this.

The new fellowship programs join those located at Saint Lukes and Roosevelt Hospitals, Addiction Institute of New York; Boston University Medical Center; University of Cincinnati College of Medicine; Geisinger Health System at Marworth, Waverly, PA; University of Minnesota Medical School; New York University School of Medicine; The University at Buffalo (SUNY) School of Medicine; University of Florida; University of Maryland School of Medicine; and the University of Wisconsin.

Our workforce projections suggest that, by 2020, we will need 50 addiction medicine fellowship training programs with 200 physician slots, said Richard Blondell, MD, Chair of the Foundations Training and Accreditation Committee, and Professor of Family Medicine at the University of Buffalo School of Medicine. One of the main obstacles to establishing these programs is funding.

The ABAM Foundation-accredited fellowship programs provide subspecialty training, which is offered to physicians already trained in a specialty such as internal medicine, family medicine, pediatrics, psychiatry, emergency medicine, surgery, preventive medicine, or obstetrics and gynecology.

The American Board of Psychiatry and Neurology offers its own fellowships in the psychiatry subspecialty of addiction psychiatry. There are 45 addiction psychiatry fellowship programs in the U.S.

The new training programs have been established at a time of increasing promise for addiction treatment, and increased need for trained treatment providers. Recent scientific discoveries have confirmed that addiction is a chronic disease of the brain caused by biological and developmental factors, with unique vulnerabilities and pathology, and a predictable course, if not interrupted by effective treatment. An increasing number of medically based addiction treatments have recently become available. Expanded coverage and demand for addiction medicine physicians will increase, as 30 million formerly uninsured Americans become covered under the Patient Protection and Affordable Care Act.

Visit link:

Eight Addiction Medicine Fellowship Programs Accredited by ABAM Foundation

Regenerative Medicine Annual Report Highlights Growth and Promise of Sector, Calls for National Strategy

WASHINGTON, April 17, 2013 /PRNewswire/ -- The Regenerative Medicine Annual Report, released today at the Alliance for Regenerative Medicine's (ARM) first annual Regen Med Investor Day, provides an overview of the tremendous growth and progress in the regenerative medicine (RM) sector during the past year. The 70-page report includes in-depth information on RM products currently available, details on late stage clinical trials and financial information such as fundraisings and market performance. The Report also outlines the elements of a US national strategy to support this sector.

With more than 100 RM products on the market, and an estimated 2,500 ongoing clinical trials worldwide, the field is making a significant impact on the treatment of chronic and life threatening diseases. Products currently available or in clinical development encompass diverse therapeutic areas such as oncology, cardiovascular and ocular diseases, wound healing, autoimmune disorders and spinal cord injuries. There are now more than 700 companies worldwide with a RM focus, ranging from divisions of multinational corporations to small organizations. Revenue from RM products on the market in 2012 exceeded $1billion and more than another $1 billion in combined public and private funding was invested into the sector.

"Unlike many therapeutics currently available that are designed to address symptoms of disease or delay disease progression, RM products have the potential to cure or significantly change the course of disease," said Geoff MacKay, Chairman of ARM and President and CEO of Organogenesis Inc. "We are thrilled with the progress that has been made in the field and are dedicated to continuing our work with regulatory agencies, policy makers and payers to further define strategies to streamline and support the commercialization of additional RM products."

The second Regenerative Medicine Annual Report is available online at http://www.alliancerm.org and in a limited print edition. Below are highlights of the report:

"While significant clinical progress has been made in progressing life-changing regenerative medicine therapies toward commercialization, there are still many regulatory, reimbursement and financial challenges to address before the field can reach its full potential," said Michael Werner, Executive Director of ARM. "Many countries have national programs in place for regenerative medicine, and it is critical that the United States develops a national strategy to support our U.S-based, life science-focused public and private companies and research institutions."

About the Alliance for Regenerative Medicine

The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based non-profit organization that promotes legislative, regulatory, reimbursement, and financing initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, and provides services to support the growth of its member companies and organizations. Prior to the formation of ARM, there was no advocacy organization operating in Washington, DC to specifically represent the interests of regenerative medicine companies, research institutions, investors, and patient groups supporting more rapid adoption of technologies in our field. To learn more about ARM or to become a member, visit http://www.alliancerm.org.

Media Contact: Michelle Linn Linnden Communications Phone: 774-696-3803

See the original post here:

Regenerative Medicine Annual Report Highlights Growth and Promise of Sector, Calls for National Strategy

Mayo Medical School evolving

Mayo Medical School will undergo evolutionary change rather than revolutionary change, the school's dean told audience members during a presentation with more than 200 in attendance, most of them high schoolers.

"I consider this a recruiting talk, so I'm hoping I'm successful," said Dr. Sherine Gabriel, the school's dean and a Mayo Clinic specialist in rheumatology and epidemiology.

An online service is needed to view this article in its entirety. You need an online service to view this article in its entirety.

Need an account? Create one now.

kAmv23C:6= E@=5 E96 J@F?8 A6@A=6[ D@>6 @7 H9@> :?5:42E65 E96J 2C6 :?E6C6DE65 😕 AFCDF:?8 42C66CD 2D A9JD:4:2?D[ E92E D49@@= @77:4:2=D H2?E E@ C64CF:E E9@F89E =6256CD H9@ H:== 92G6 E96 23:=:EJ E@ EC2?D7@C> 962=E9 42C6 7C@> H:E9:? @?46 E96J 4@>A=6E6 >65:42= D49@@=]k^Am

kAm%9FD[ |2J@ 😀 =@@<:?8 7@C 2AA=:42?ED H9@ 56>@?DEC2E6 D<:==D DF49 2D =6256CD9:A[ E62>H@C<[ 4@>>F?:EJ D6CG:46[ 25G@424J[ 24256>:4 249:6G6>6?E 2?5 =:76 6IA6C:6?46]k^Am

kAm!6C764E $p% 2?5 |rp% D4@C6D 5@ ?@E ?646DD2C:=J 8F2C2?E66 2 DA@E 😕 E96 D49@@=VD 4=2DD @7 d_ W23@FE ca @7 H9@> AFCDF6 D@=6=J |]s] 568C66DX] #2E96C[ E@ C:D6 E@ E96 E@A @7 =2DE J62CVD c[f__ 2AA=:42E:@?D[ AC@DA64E:G6 DEF56?ED 925 E@ D9@H 2 3C@25 :?E6C6DE 😕 962=E9 42C6[ 2 56D:C6 E@ >2<6 2 5:776C6?46 2?5 2 F?:BF6 A@E6?E:2= E@ 249:6G6]k^Am

kAmx?4C62D:?8=J[ v23C:6= D2:5 5FC:?8 96C E2=< E:E=65 Qp }6H ':D:@? 7@C |2J@ |65:42= $49@@=[Q |2J@ H:== =@@< E@ :ED >65:42= D49@@= 8C25F2E6D E@ >2<6 2 5:776C6?46 :? E96 ?2E:@?VD 962=E942C6 DJDE6>]k^Am

kAmvC25F2E6D @7 E96 >65:42= D49@@= H:== ?@E @?=J 86E :?G@=G65 😕 E96 D4:6?E:7:4 C:8@C @7 >65:4:?6 H:E9 2 8@2= @7 962=:?8 A2E:6?ED[ 3FE E96J H:== 2=D@ H@C< QE@ 962= @FC 2:=:?8 >65:42= DJDE6>]Qk^Am

kAm|2J@[ v23C:6= D2:5[ 92D QE96 =6824J 2?5 E6?24:EJQ E@ 249:6G6 DF446DD 2?5 AC6A2C6 E96 962=E942C6 =6256CD @7 E96 7FEFC6 H:E9 E96 E@@=D[ D<:==D[ ]Qk^Am

Read the original post:

Mayo Medical School evolving

Senate committee passes medical school funding bill

Posted on | April 17, 2013 | Comments

State Sen. Richard Roth, D-Riverside, and G. Richard Olds, founding dead of the UCR school of medicine, testify at Wednesdays hearing.

The Senate Education Committee unanimously approved legislation this morning that would appropriate $15 million for UC Riversides school of medicine.

The bill, Senate Bill 21 by state Sen. Richard Roth, D-Riverside, is virtually identical to Assembly Bill 27, by Assemblyman Jose Medina, D-Riverside. That measure passed the Assembly Higher Education Committee last month.

Notably missing from todays testimony were representatives of the American Federation of State, County and Municipal Employees. The influential unions chief lobbyist testified against the medical school money last month, contending that it would be wrong to give UC more money when it is mistreating its AFSCME-represented workers.

Wednesday, Roth said supporters of the school and the union have come to terms.

AFSCME wanted to make sure that the money ultimately appropriated for this medical school was used for this medical school and the education of physicians who largely remain in Riverside County providing medical care to the underserved, Roth said.

A committee analysis of the bill shows that The Press-Enterprise is among the supporters of SB 21.

By: Jim Miller

Comments

Excerpt from:

Senate committee passes medical school funding bill

Liberty Global Bidding for Germany's Kabel Deutschland (Report)

Matthew Staver/Bloomberg via Getty Images

John Malone's Liberty Global is the world's largest cable operator.

COLOGNE, Germany Is John Malone considering a takeover bid for Kabel Deutschland, Germany's largest cable operator? An "exclusive" report in Germany's Manager Magazin says Malone's Liberty Global is preparing a bid for the German cable giant to preempt a potential takeover offer from British mobile phone carrier Vodafone.

The German cable market, the largest in Europe, is still posting strong growth, in large part due to the roll-out of so-called triple play offerings, whereby customers pay cable providers for broadband Internet and telephone services in addition to cable TV. The size, and health, of the German cable market led to the speculation that Vodafone was eyeing a bid for Kabel Deutschland.

PHOTOS:10 High-Paid Entertainment CEOs

According to the report, Liberty is looking to add Kabel Deutschland, and its 8.5 million customers, to its global cable empire. Malone's company, the world's largest cable group, completed its merger of Germany's second and third largest cable operators, Unitymedia and KBW, in late 2011. At the time, Liberty was forced to make significant concessions to receive regulatory approval for the deal.

Malone has been on a European buying spree of late, snatching up Brit cable operator Virgin Media for $23.3 billion earlier this year, recently put up a further $810 million for a minority stake in Ziggo, the largest cable operator in the Netherlands and upped its majority stake in Belgian cable group Telenet.

Polo Tang, an analyst at UBS, wrote that the while reports of a take-over bid "is seen as positive for sentiment for Kabel Deutschland, we believe any offer from Liberty Global could face significant competition issues from the (German) Federal Cartel Office."

STORY:EU Clears Liberty Global Deal for U.K. Cable Firm Virgin Media

Tang points out that for Liberty's merger of Unitymedia and Kabel BW, German authorities chose to view cable TV as a single market not as part of a broader triple play business where Liberty competes with broadband and mobile phone groups such as Deutsche Telekom and Vodafone. "On this definition, cable re-unification (in Germany) is unlike in the near term (2-3 years)," Tang wrote. He added a full takeover of Kabel Deutschland, which would give Malone a dominant position in the German cable business, could complicated Liberty's bid for Virgin Media, a deal that still has to be approved by European competition authorities.

See the article here:

Liberty Global Bidding for Germany's Kabel Deutschland (Report)

Liberty Global Preparing Bid for Largest German Cable Operator (Report)

Matthew Staver/Bloomberg via Getty Images

John Malone's Liberty Global is the world's largest cable operator.

COLOGNE, Germany Is John Malone considering a takeover bid for Kabel Deutschland, Germany's largest cable operator? An "exclusive" report in Germany's Manager Magazin says Malone's Liberty Global is preparing a bid for the German cable giant to preempt a potential takeover offer from British mobile phone carrier Vodafone.

The German cable market, the largest in Europe, is still posting strong growth, in large part due to the roll-out of so-called triple play offerings, whereby customers pay cable providers for broadband Internet and telephone services in addition to cable TV. The size, and health, of the German cable market led to the speculation that Vodafone was eyeing a bid for Kabel Deutschland.

PHOTOS:10 High-Paid Entertainment CEOs

According to the report, Liberty is looking to add Kabel Deutschland, and its 8.5 million customers, to its global cable empire. Malone's company, the world's largest cable group, completed its merger of Germany's second and third largest cable operators, Unitymedia and KBW, in late 2011. At the time, Liberty was forced to make significant concessions to receive regulatory approval for the deal.

Malone has been on a European buying spree of late, snatching up Brit cable operator Virgin Media for $23.3 billion earlier this year, recently put up a further $810 million for a minority stake in Ziggo, the largest cable operator in the Netherlands and upped its majority stake in Belgian cable group Telenet.

Polo Tang, an analyst at UBS, wrote that the while reports of a take-over bid "is seen as positive for sentiment for Kabel Deutschland, we believe any offer from Liberty Global could face significant competition issues from the (German) Federal Cartel Office."

STORY:EU Clears Liberty Global Deal for U.K. Cable Firm Virgin Media

Tang points out that for Liberty's merger of Unitymedia and Kabel BW, German authorities chose to view cable TV as a single market not as part of a broader triple play business where Liberty competes with broadband and mobile phone groups such as Deutsche Telekom and Vodafone. "On this definition, cable re-unification (in Germany) is unlike in the near term (2-3 years)," Tang wrote. He added a full takeover of Kabel Deutschland, which would give Malone a dominant position in the German cable business, could complicated Liberty's bid for Virgin Media, a deal that still has to be approved by European competition authorities.

Go here to read the rest:

Liberty Global Preparing Bid for Largest German Cable Operator (Report)

Liberty Bell Bank Reports First Quarter 2013 Results of Operations

MARLTON, N.J.--(BUSINESS WIRE)--

Liberty Bell Bank (LBBB) today reported net income of $202,000 or $0.06 per diluted share for the three months ended March 31, 2013, compared to net income of $35,000 or $0.01 per diluted share for the same period in 2012, an increase of $167,000 or $0.05 per diluted share. The increased earnings are primarily the result of gains on the sale of securities available for sale of $156,000. At March 31, 2013, the Bank remains well capitalized by all regulatory measures.

In addition to gains on the sale of securities available for sale, the increase in earnings also was due to a $67,000 decrease in total non-interest expense, a $51,000 decrease in the provision for loan losses, a $12,000 decrease in write-downs on other real estate owned and a $3,000 decrease in income tax expense. These positive variances were partially offset by reduced net interest income of $94,000 and a decrease in service charges on deposit accounts and other income of $28,000.

The decrease of $94,000 in net interest income for the three months ended March 31, 2013 as compared to the three months ended March 31, 2012, was due to a $219,000 decrease in interest and dividend income partially offset by a $125,000 reduction in interest expense, primarily from a decrease of interest on deposits. The decrease in interest and dividend income was due primarily to a decrease of $271,000 in interest and fees from loans, offset partially by an increase of $54,000 in interest on securities available for sale.

The decrease of $271,000 in interest and fees from loans was due primarily to a 46 basis point reduction of the yield from the loan portfolio from 5.77% to 5.31%. In addition, the average loan balance outstanding for the first three months of 2013 as compared to the first three months of 2012 decreased by $8.5 million. The increase of $54,000 in interest on securities available for sale was due primarily to an increase in the average balance outstanding from $13.3 million to $26.3 million.

Net interest margin for the first quarter of 2013 was 3.51%, a decrease of 0.26% from the 3.77% net interest margin for the first quarter of 2012. The margin decrease was mainly the result of a 0.59% lower yield from interest-earning assets partially offset by a 0.35% reduction in the rate paid for interest-bearing deposits.

Total assets at March 31, 2013 were $172.2 million, representing a decrease of $2.1 million from $174.3 million at December 31, 2012. The decrease was due primarily to cash and cash equivalents, which decreased $6.9 million and net loans which decreased $2.6 million from December 31, 2012. These decreases were partially offset by investments which increased $6.9 million and other assets which increased $297,000. Other real estate owned increased $272,000 from $5.6 million at December 31, 2012 to $5.9 million at March 31, 2013.

Total deposits decreased $2.1 million to $152.7 million at March 31, 2013 from $154.8 million at December 31, 2012. The decrease was primarily due to a $2.4 million decrease in interest-bearing accounts offset by a $374,000 increase in non-interest bearing accounts.

The Bank continues to increase non-interest bearing deposit accounts. Total non-interest bearing deposit accounts at March 31, 2013 were $15.8 million as compared to $15.4 million at December 31, 2012. The growth in non-interest bearing deposits was from the Banks local area market.

The decrease in interest-bearing deposit accounts of $2.4 million was due primarily to a decrease in certificates of deposit, our highest cost deposits, which decreased $3.0 million from $68.8 million at December 31, 2012 to $65.8 million at March 31, 2013.

Originally posted here:

Liberty Bell Bank Reports First Quarter 2013 Results of Operations

Liberty Global Prepares Acquisition of Kabel Deutschland -Report

Global cable group Liberty Global Inc. (LBTYB) is preparing a takeover bid for Germany's Kabel Deutschland Holding AG (KD8.XE), Manager magazine reports in the advance release of an article to be published in Friday's edition.

Liberty Global CEO Michael Fries and CEO of German subsidiary Unitymedia KabelBW Lutz Schueler are working on the offer, the report says.

Liberty Global and Unitymedia KabelBW declined to comment, as did Kabel Deutschland.

The takeover plan comes after Vodafone Group PLC (VOD.LN) showed interest in acquiring Kabel Deutschland, which was reported by Dow Jones in mid-February.

In February, the German cartel office blocked Kabel Deutschland's attempt to takeover competitor Tele Columbus, citing antitrust concerns, which could likewise be an obstacle for Liberty Global's plans.

Liberty Global already owns the country's No. 2 and No. 3 cable operators Unitymedia and Kabel BW, which it has combined into one business to create its German subsidiary.

Newspaper website: http://manager-magazin.de

Write to the Frankfurt Bureau at djnews.frankfurt@dowjones.com

Copyright 2013 Dow Jones Newswires

Go here to read the rest:

Liberty Global Prepares Acquisition of Kabel Deutschland -Report

First Liberty Power Project Funding Announcement

LAS VEGAS, April 17, 2013 /PRNewswire/ -- First Liberty Power Corp. (FLPC), an innovative and diversified mine exploration and development company focused on bringing to market "Mined in America" strategic industrial minerals, is pleased to announce it has obtained a commitment for $500,000 in funding, which will provide the impetus needed to achieve the short term goal of initial mining operations on the Fencemaker Antimony Property.

This funding will allow the company to commence the additional steps required for safe and appropriate access for long-term mining operations, as well as to achieve initial mine production. CEO Don Nicholson commented, "We are very pleased to be acquiring this non-dilutive funding and we are now planning the definitive implementation timeline for the procedures that will follow the water removal from the mine. Closing of this transaction and first cash provisioning is expected next week. We will provide additional details at that time under our Pathways of Progress program, together with ongoing operational updates."

First Liberty Power's partner in this finance is Chicago Venture Partners, who provided a statement in regards to this financing, "We at Chicago Venture Partners, after observing the positive progress made by First Liberty Power in recent months, are very pleased to have the opportunity to help the Company move forward in these next stages towards initial production on the Antimony project. It is difficult, and quite uncommon, for an exploration stage company to make the transition from development to production, and we are very excited to be a part of the process with First Liberty."

First Liberty Power CFO Mario Beckles reaffirmed that company procedures are in place to optimally allocate funds as required for the Fencemaker operations. Mr. Beckles expanded on the statement by saying, "since my arrival at First Liberty Power, an objective of the management team has been to review and expand the financial framework and guidelines associated with our financial operations. This has resulted in the company putting robust reporting programs in place, and additional, more stringent internal controls. We believe that combined with our other operational initiatives, and ongoing efforts in seeking further investments into the company, we will also be able to progress on the development of our equally important Lithium and Vanadium/Uranium projects in the near future."

ABOUT FIRST LIBERTY POWER CORPORATION: First Liberty Power Corporation (FLPC) is an innovative and diversified mine exploration and development company focused on bringing to market "Mined in America" strategic industrial minerals. Our corporate philosophy is driven by a dedication to Pathways of Progress, our program of best corporate practices designed to drive us rapidly towards mine production & milling, to the greatest possible benefit of FLPC shareholders, investors and mining partners, while ensuring safety, environmental integrity, and good governance. Presently, FLPC has interests in four properties: the Fencemaker Antimony project in Nevada, the Lida Valley and Smoky Valley Lithium Brine projects in Nevada, and the San Juan Vanadium / Uranium project in Utah. http://www.firstlibertypower.com

Notice Regarding Forward-Looking Statements

This current report contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future plans of the company, the prospects for our mineral properties, and our ability to raise necessary working capital.

Actual results could differ from those projected in any forward-looking statements due to numerous factors, including the inherent uncertainties associated with mineral exploration and difficulties associated with obtaining financing on acceptable terms. We are not in control of metals prices and these could vary to make development uneconomic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that they will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the SEC.

Go here to see the original:

First Liberty Power Project Funding Announcement

Liberty Global preparing Kabel Deutschland bid: report

FRANKFURT (Reuters) - U.S. cable company Liberty Global is preparing a takeover offer for Kabel Deutschland, Manager Magazin reported, sending shares in Germany's biggest cable company higher.

By preparing a bid, Liberty Global wants to steal a march on UK-based telecommunications company Vodafone, which is also interested in buying Kabel Deutschland, the monthly magazine said in an excerpt of an article to be published on Friday. The excerpt did not cite sources.

Kabel Deutschland and Liberty Global declined to comment.

Any attempt by Liberty Global to buy Kabel Deutschland, which has a market value of 6.2 billion euros ($8.1 billion), would likely meet resistance from anti-trust regulators as the U.S. company already owns Unitymedia Kabel BW, Germany's No. 2 cable company.

The German cartel office blocked a similar deal earlier this year. Kabel Deutschland had wanted to buy Germany's No. 3 cable company Tele Columbus, but the regular said such the move would cement a duopoly and crimp competition.

A banker familiar with the sector said he could imagine that Liberty Global was only preparing a bid to drive up the price of Kabel Deutschland beyond what Vodafone would be willing to pay.

A source had told Reuters earlier this year that Vodafone was considering a bid for Kabel Deutschland to expand its services in Europe's biggest economy.

Shares in Kabel Deutschland were trading 5.2 percent higher at 73.94 euros by 0955 GMT.

On Monday, Liberty Global won unconditional EU regulatory approval for its $15.8 billion takeover of Britain's Virgin Media.

(Reporting by Maria Sheahan; Additional reporting by Sabine Wollrab and Arno Schuetze; Editing by Mark Potter)

More here:

Liberty Global preparing Kabel Deutschland bid: report